DOI: 10.1055/s-00000025

Hormone and Metabolic Research


Colao A, Zgliczyński W, Komorowski J. et al.
Efficacy and safety of high-dose long-acting repeatable octreotide as monotherapy or in combination with pegvisomant or cabergoline in patients with acromegaly not adequately controlled by conventional regimens: results of an open-label, multicentre study.

Endokrynol Pol 2019;
70: 305-312

Download Bibliographical Data